| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.38B | 38.92B | 36.83B | 39.10B | 37.51B | 37.76B |
| Gross Profit | 13.48B | 13.24B | 12.17B | 11.82B | 11.91B | 11.26B |
| EBITDA | 8.05B | 7.75B | 7.09B | 6.61B | 6.99B | 6.40B |
| Net Income | 5.27B | 4.83B | 3.73B | 3.74B | 4.24B | 3.76B |
Balance Sheet | ||||||
| Total Assets | 49.71B | 51.87B | 52.02B | 49.84B | 47.42B | 46.27B |
| Cash, Cash Equivalents and Short-Term Investments | 16.77B | 17.32B | 13.92B | 11.02B | 12.91B | 11.76B |
| Total Debt | 3.81B | 3.91B | 4.76B | 5.31B | 4.06B | 5.33B |
| Total Liabilities | 14.52B | 15.33B | 18.17B | 18.26B | 18.22B | 20.02B |
| Stockholders Equity | 35.19B | 36.53B | 33.86B | 31.58B | 29.20B | 26.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.32B | 4.49B | 2.45B | 3.43B | 3.29B |
| Operating Cash Flow | 0.00 | 6.38B | 5.59B | 3.86B | 5.00B | 4.22B |
| Investing Cash Flow | 0.00 | 215.16M | -526.25M | -2.94B | -1.14B | -397.28M |
| Financing Cash Flow | 0.00 | -3.19B | -2.15B | -2.07B | -2.62B | -638.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥114.19B | 2.15 | ― | 2.30% | -0.22% | 25.09% | |
76 Outperform | ¥149.50B | 11.95 | ― | 2.77% | 1.43% | 91.97% | |
73 Outperform | ¥27.39B | 9.01 | ― | 5.04% | -2.29% | -41.92% | |
67 Neutral | ¥388.03B | -16.12 | 7.93% | 2.32% | -2.26% | -10.86% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥121.66B | 45.55 | 6.98% | 3.13% | -2.13% | 37.10% | |
49 Neutral | ¥18.18B | 743.26 | ― | 3.24% | -3.73% | -143.19% |